-
公开(公告)号:US07410949B2
公开(公告)日:2008-08-12
申请号:US11328743
申请日:2006-01-10
申请人: Waleed Danho , George Ehrlich , David C Fry , Wajiha Khan , Joseph Swistok
发明人: Waleed Danho , George Ehrlich , David C Fry , Wajiha Khan , Joseph Swistok
CPC分类号: C07K14/575 , A61K38/00 , C07K14/57545
摘要: Provided herein are neuropeptide-2 receptor agonists of the formula (I): Y—R1—R2—X—R3—R4—R5—R6—R7—R8—R9—R10—R11—R12—R13—R14—NH2, (I) as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity.
摘要翻译: 本文提供了式(I)的神经肽-2受体激动剂:<?in-line-formula description =“In-line Formulas”end =“lead”?> YR sub> > 2 i> -XR 3 3 -R 4 -R 5 5 -R 6 -S < > 7 sub> 8 i> i> i> i> i> (I)&lt;β-in-line-formula description =“12” - > 在线配方“end =”tail“?>以及其药学上可接受的盐,衍生物和片段,其中取代基如说明书中公开的那些。 这些化合物和含有它们的药物组合物可用于治疗诸如肥胖的疾病。
-
公开(公告)号:US20120101037A1
公开(公告)日:2012-04-26
申请号:US13274372
申请日:2011-10-17
CPC分类号: C07K14/605 , A61K38/00 , A61K38/22
摘要: The present invention provides compounds which are analogs of glucose-dependent insulinotropic polypeptide (GIP) and pharmaceutically acceptable salts of such compounds. These compounds have activity as agonists of GIP receptor.
摘要翻译: 本发明提供了作为葡萄糖依赖性促胰岛素多肽(GIP)的类似物和这些化合物的药学上可接受的盐的化合物。 这些化合物具有作为GIP受体激动剂的活性。
-
公开(公告)号:US07642244B2
公开(公告)日:2010-01-05
申请号:US11607230
申请日:2006-12-01
申请人: Karin Conde-Knape , Waleed Danho , George Ehrlich , Nader Fotouhi , David Charles Fry , Wajiha Khan , Anish Konkar , Cristina Martha Rondinone , Joseph Swistok , Rebecca Anne Taub , Jefferson Wright Tilley
发明人: Karin Conde-Knape , Waleed Danho , George Ehrlich , Nader Fotouhi , David Charles Fry , Wajiha Khan , Anish Konkar , Cristina Martha Rondinone , Joseph Swistok , Rebecca Anne Taub , Jefferson Wright Tilley
CPC分类号: C07K14/57545 , A61K38/00 , A61K47/60
摘要: Provided herein are neuropeptide-2 receptor agonists of the formula (I): as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. X is 4-oxo-6-(1-piperazinyl)-3(4H)-quinazoline-acetic acid (Pqa). These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.
摘要翻译: 本文提供了式(I)的神经肽-2受体激动剂:以及其药学上可接受的盐,衍生物和片段,其中取代基如说明书中公开的那些。 X是4-氧代-6-(1-哌嗪基)-3(4H) - 喹唑啉 - 乙酸(Pqa)。 这些化合物和含有它们的药物组合物可用于治疗疾病,例如肥胖症和糖尿病。
-
公开(公告)号:US20060160742A1
公开(公告)日:2006-07-20
申请号:US11328743
申请日:2006-01-10
申请人: Waleed Danho , George Ehrlich , David Fry , Wajiha Khan , Joseph Swistok
发明人: Waleed Danho , George Ehrlich , David Fry , Wajiha Khan , Joseph Swistok
CPC分类号: C07K14/575 , A61K38/00 , C07K14/57545
摘要: Provided herein are neuropeptide-2 receptor agonists of the formula (I): Y—R1—R2—X—R3—R4—R5—R6—R7—R8—R9—R10—R11—R12—R13—R14—NH2 (I), as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity.
摘要翻译: 本文提供了式(I)的神经肽-2受体激动剂:<?in-line-formula description =“In-line Formulas”end =“lead”?> YR <1> > 2 i> -XR 3 3 -R 4 -R 5 5 -R 6 -S < > 7 sub> 8 i> i> i> i> i> (I),&lt;β-in-line-formula description =“ 在线配方“end =”tail“?>以及其药学上可接受的盐,衍生物和片段,其中取代基如说明书中公开的那些。 这些化合物和含有它们的药物组合物可用于治疗诸如肥胖的疾病。
-
公开(公告)号:US08268784B2
公开(公告)日:2012-09-18
申请号:US12536688
申请日:2009-08-06
申请人: Karin Conde-Knape , Waleed Danho , George Ehrlich , Nader Fotouhi , David Charles Fry , Wajiha Khan , Anish Konkar , Cristina Martha Rondinone , Joseph Swistok , Rebecca Anne Taub , Jefferson Wright Tilley
发明人: Karin Conde-Knape , Waleed Danho , George Ehrlich , Nader Fotouhi , David Charles Fry , Wajiha Khan , Anish Konkar , Cristina Martha Rondinone , Joseph Swistok , Rebecca Anne Taub , Jefferson Wright Tilley
CPC分类号: C07K14/57545 , A61K38/00 , A61K47/60
摘要: Provided herein are neuropeptide-2 receptor agonists of the formula (I): as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. X is 4-oxo-6-(1-piperazinyl)-3(4H)-quinazoline-acetic acid (Pqa). These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.
摘要翻译: 本文提供了式(I)的神经肽-2受体激动剂:以及其药学上可接受的盐,衍生物和片段,其中取代基如说明书中公开的那些。 X是4-氧代-6-(1-哌嗪基)-3(4H) - 喹唑啉 - 乙酸(Pqa)。 这些化合物和含有它们的药物组合物可用于治疗疾病,例如肥胖症和糖尿病。
-
公开(公告)号:US09023986B2
公开(公告)日:2015-05-05
申请号:US13274372
申请日:2011-10-17
IPC分类号: C07K14/00 , C07K14/575 , A61K38/22 , C07K14/605 , A61K38/00
CPC分类号: C07K14/605 , A61K38/00 , A61K38/22
摘要: The present invention provides compounds which are analogs of glucose-dependent insulinotropic polypeptide (GIP) and pharmaceutically acceptable salts of such compounds. These compounds have activity as agonists of GIP receptor.
摘要翻译: 本发明提供了作为葡萄糖依赖性促胰岛素多肽(GIP)的类似物和这些化合物的药学上可接受的盐的化合物。 这些化合物具有作为GIP受体激动剂的活性。
-
公开(公告)号:US20100137223A1
公开(公告)日:2010-06-03
申请号:US12536688
申请日:2009-08-06
申请人: Karin Conde-Knape , Waleed Danho , George Ehrlich , Nader Fotouhi , David Charles Fry , Wajiha Khan , Anish Konkar , Cristina Martha Rondinone , Joseph Swistok , Rebecca Anne Taub , Jefferson Wright Tilley
发明人: Karin Conde-Knape , Waleed Danho , George Ehrlich , Nader Fotouhi , David Charles Fry , Wajiha Khan , Anish Konkar , Cristina Martha Rondinone , Joseph Swistok , Rebecca Anne Taub , Jefferson Wright Tilley
CPC分类号: C07K14/57545 , A61K38/00 , A61K47/60
摘要: Provided herein are neuropeptide-2 receptor agonists of the formula (I): as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. X is 4-oxo-6-(1-piperazinyl)-3(4H)-quinazoline-acetic acid (Pqa). These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.
摘要翻译: 本文提供了式(I)的神经肽-2受体激动剂:以及其药学上可接受的盐,衍生物和片段,其中取代基如说明书中公开的那些。 X是4-氧代-6-(1-哌嗪基)-3(4H) - 喹唑啉 - 乙酸(Pqa)。 这些化合物和含有它们的药物组合物可用于治疗疾病,例如肥胖症和糖尿病。
-
公开(公告)号:US20070135351A1
公开(公告)日:2007-06-14
申请号:US11607230
申请日:2006-12-01
申请人: Karin Conde-Knape , Waleed Danho , George Ehrlich , Nader Fotouhi , David Fry , Wajiha Khan , Anish Konkar , Cristina Rondinone , Joseph Swistok , Rebecca Taub , Jefferson Tilley
发明人: Karin Conde-Knape , Waleed Danho , George Ehrlich , Nader Fotouhi , David Fry , Wajiha Khan , Anish Konkar , Cristina Rondinone , Joseph Swistok , Rebecca Taub , Jefferson Tilley
CPC分类号: C07K14/57545 , A61K38/00 , A61K47/60
摘要: Provided herein are neuropeptide-2 receptor agonists of the formula (I): as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.
摘要翻译: 本文提供了式(I)的神经肽-2受体激动剂:以及其药学上可接受的盐,衍生物和片段,其中取代基如说明书中公开的那些。 这些化合物和含有它们的药物组合物可用于治疗疾病,例如肥胖症和糖尿病。
-
公开(公告)号:US20110172147A1
公开(公告)日:2011-07-14
申请号:US13072048
申请日:2011-03-25
申请人: Karin Conde-Knape , Waleed Danho , Nader Fotouhi , David Charles Fry , Wajiha Khan , Anish Konkar , Cristina Martha Rondinone , Joseph Swistok , Jefferson Wright Tilley
发明人: Karin Conde-Knape , Waleed Danho , Nader Fotouhi , David Charles Fry , Wajiha Khan , Anish Konkar , Cristina Martha Rondinone , Joseph Swistok , Jefferson Wright Tilley
CPC分类号: C07K14/575 , A61K38/00 , C07K14/57545
摘要: Provided herein are neuropeptide-2 receptor agonists of the formula (I): as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.
摘要翻译: 本文提供了式(I)的神经肽-2受体激动剂:以及其药学上可接受的盐,衍生物和片段,其中取代基如说明书中公开的那些。 这些化合物和含有它们的药物组合物可用于治疗疾病,例如肥胖症和糖尿病。
-
公开(公告)号:US20100179093A1
公开(公告)日:2010-07-15
申请号:US12610417
申请日:2009-11-02
申请人: Waleed Danho , Nader Fotouhi , David Charles Fry , Wajiha Khan , Joseph Swistok , Jefferson Wright Tilley
发明人: Waleed Danho , Nader Fotouhi , David Charles Fry , Wajiha Khan , Joseph Swistok , Jefferson Wright Tilley
CPC分类号: A61K38/2271
摘要: Provided herein are neuropeptide-2 receptor agonists of the formula (I): as well as pharmaceutically acceptable salts, derivatives and fragments thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of diseases such as, for example, obesity and diabetes.
摘要翻译: 本文提供了式(I)的神经肽-2受体激动剂:以及其药学上可接受的盐,衍生物和片段,其中取代基如说明书中公开的那些。 这些化合物和含有它们的药物组合物可用于治疗疾病,例如肥胖症和糖尿病。
-
-
-
-
-
-
-
-
-